Company intelligence / Profile preview

PLx Acquisition Company

Ownership: Private
Development stage: Other

Overview

PLx Acquisition Company, a subsidiary of Greenwood Brands, was formed as an acquisition vehicle. It notably served as the stalking horse bidder in April 2023 for an asset purchase agreement to acquire VAZALORE and substantially all assets of PLx Pharma Inc., a specialty pharmaceutical firm focusing on GI-safer aspirin products for cardiovascular indications.

Industry: Investors

Beyond the preview

Go deeper on PLx Acquisition Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PLx Acquisition Company.

Explore the full profile